153
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Progesterone and not estrogens or androgens causes breast cancer

ORCID Icon &
Pages 217-222 | Received 03 Nov 2023, Accepted 21 Nov 2023, Published online: 10 Jan 2024
 

Acknowledgements

The authors thank Amanda Prowse and Jan Egberts (T4C Communications, Hilversum, The Netherlands) for their valuable editorial support. Data sharing is not applicable to this article as no new data were created or analyzed in this study.

Potential conflict of interest

H. J. T. Coelingh Bennink is President of Pantarhei Oncology (subsidiary of Pantarhei Bioscience), the company developing the fetal estrogen estetrol for the treatment of advanced breast and prostate cancer, but this is outside the scope of the present letter. F. Z. Stanczyk has no conflict of interest.

Source of funding

None.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 277.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.